KCM
Kennedy Capital Management Portfolio holdings
AUM
$4.19B
This Quarter Return
+9.84%
1 Year Return
+21.14%
3 Year Return
+81.48%
5 Year Return
+215.31%
10 Year Return
+405%
AUM
$4.19B
AUM Growth
+$4.19B
(+0.2%)
Cap. Flow
-$239M
Cap. Flow
% of AUM
-5.69%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
690
New
48
Increased
226
Reduced
295
Closed
109
Top Buys
| 1 |
Genpact
G
|
$15.3M |
| 2 |
SharkNinja
SN
|
$11.8M |
| 3 |
Mercury Systems
MRCY
|
$9.65M |
| 4 |
SPX Corp
SPXC
|
$8.6M |
| 5 |
Old Second Bancorp
OSBC
|
$8.54M |
Top Sells
| 1 |
Hexcel
HXL
|
$22.7M |
| 2 |
Boot Barn
BOOT
|
$18.9M |
| 3 |
Columbia Banking Systems
COLB
|
$14.4M |
| 4 |
Chart Industries
GTLS
|
$14M |
| 5 |
Informatica
INFA
|
$13.8M |
Sector Composition
| 1 | Financials | 20.27% |
| 2 | Industrials | 19.02% |
| 3 | Healthcare | 16.19% |
| 4 | Technology | 14.06% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
American Healthcare REIT
AHR
$7.03B
| $9.45M | 0.23% |
257,344
+229,165
| +813% | +$8.42M |
|
152
Manitowoc
MTW
$349M
| $9.36M | 0.22% |
778,657
-51,300
| -6% | -$617K |
|
153
Merck
MRK
$212B
| $9.3M | 0.22% |
117,452
-18,816
| -14% | -$1.49M |
|
154
Axcelis
ACLS
$2.45B
| $9.28M | 0.22% |
133,206
+3,325
| +3% | +$232K |
|
|
UMH
155
UMH Properties
UMH
$1.28B
| $9.25M | 0.22% |
550,879
-21,728
| -4% | -$365K |
|
156
Aaon
AAON
$6.58B
| $9.23M | 0.22% |
125,088
+75,937
| +154% | +$5.6M |
|
157
UGI
UGI
$7.27B
| $9.23M | 0.22% |
253,301
-2,675
| -1% | -$97.4K |
|
158
Graham Corp
GHM
$527M
| $9.18M | 0.22% |
185,374
+67,139
| +57% | +$3.32M |
|
159
Plexus
PLXS
$3.62B
| $9.16M | 0.22% |
67,728
-1,122
| -2% | -$152K |
|
160
VSE Corp
VSEC
$3.34B
| $9.09M | 0.22% |
69,426
+5,143
| +8% | +$674K |
|
161
Thermon Group Holdings
THR
$858M
| $8.94M | 0.21% |
318,531
+13,000
| +4% | +$365K |
|
162
Yeti Holdings
YETI
$2.85B
| $8.91M | 0.21% |
282,712
+70,274
| +33% | +$2.22M |
|
163
Boston Scientific
BSX
$157B
| $8.9M | 0.21% |
82,878
-9,270
| -10% | -$996K |
|
164
Gilead Sciences
GILD
$140B
| $8.76M | 0.21% |
79,041
-41
| -0.1% | -$4.55K |
|
165
Ralph Lauren
RL
$18.9B
| $8.72M | 0.21% |
31,810
-24,185
| -43% | -$6.63M |
|
166
Nature's Sunshine
NATR
$301M
| $8.72M | 0.21% |
589,636
+160,002
| +37% | +$2.37M |
|
167
Equity Bancshares
EQBK
$817M
| $8.7M | 0.21% |
213,333
+104,613
| +96% | +$4.27M |
|
168
Lakeland Financial Corp
LKFN
$1.7B
| $8.7M | 0.21% |
141,500
-2,366
| -2% | -$145K |
|
|
AVDL
169
Avadel Pharmaceuticals
AVDL
$1.39B
| $8.68M | 0.21% |
981,271
+227,228
| +30% | +$2.01M |
|
170
Vertex Pharmaceuticals
VRTX
$102B
| $8.64M | 0.21% |
19,410
-1,047
| -5% | -$466K |
|
|
171
Informatica
INFA
$7.6B
| $8.64M | 0.21% |
354,715
-567,826
| -62% | -$13.8M |
|
172
Heritage Commerce
HTBK
$626M
| $8.63M | 0.21% |
868,932
-18,958
| -2% | -$188K |
|
173
TFI International
TFII
$7.93B
| $8.62M | 0.21% |
96,163
+18,049
| +23% | +$1.62M |
|
174
Mesa Laboratories
MLAB
$337M
| $8.52M | 0.2% |
90,479
-22,792
| -20% | -$2.15M |
|
175
Corcept Therapeutics
CORT
$7.51B
| $8.52M | 0.2% |
116,013
+30,090
| +35% | +$2.21M |
|